rs1799999

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_002711.4(PPP1R3A):​c.2713G>T​(p.Asp905Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.145 in 1,611,778 control chromosomes in the GnomAD database, including 29,281 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.17 ( 3429 hom., cov: 32)
Exomes 𝑓: 0.14 ( 25852 hom. )

Consequence

PPP1R3A
NM_002711.4 missense

Scores

1
6
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2O:1

Conservation

PhyloP100: 3.23

Publications

62 publications found
Variant links:
Genes affected
PPP1R3A (HGNC:9291): (protein phosphatase 1 regulatory subunit 3A) The glycogen-associated form of protein phosphatase-1 (PP1) derived from skeletal muscle is a heterodimer composed of a 37-kD catalytic subunit and a 124-kD targeting and regulatory subunit. This gene encodes the regulatory subunit which binds to muscle glycogen with high affinity, thereby enhancing dephosphorylation of glycogen-bound substrates for PP1 such as glycogen synthase and glycogen phosphorylase kinase. [provided by RefSeq, Jul 2008]
PPP1R3A Gene-Disease associations (from GenCC):
  • diabetes mellitus, noninsulin-dependent
    Inheritance: Unknown Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=8.817586E-6).
BP6
Variant 7-113878379-C-A is Benign according to our data. Variant chr7-113878379-C-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 8706.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.652 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PPP1R3ANM_002711.4 linkc.2713G>T p.Asp905Tyr missense_variant Exon 4 of 4 ENST00000284601.4 NP_002702.2 Q16821-1
PPP1R3AXM_005250473.4 linkc.2110G>T p.Asp704Tyr missense_variant Exon 5 of 5 XP_005250530.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PPP1R3AENST00000284601.4 linkc.2713G>T p.Asp905Tyr missense_variant Exon 4 of 4 1 NM_002711.4 ENSP00000284601.3 Q16821-1

Frequencies

GnomAD3 genomes
AF:
0.174
AC:
26465
AN:
151784
Hom.:
3426
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.194
Gnomad AMI
AF:
0.122
Gnomad AMR
AF:
0.213
Gnomad ASJ
AF:
0.207
Gnomad EAS
AF:
0.670
Gnomad SAS
AF:
0.398
Gnomad FIN
AF:
0.204
Gnomad MID
AF:
0.146
Gnomad NFE
AF:
0.0950
Gnomad OTH
AF:
0.179
GnomAD2 exomes
AF:
0.221
AC:
55132
AN:
249384
AF XY:
0.223
show subpopulations
Gnomad AFR exome
AF:
0.195
Gnomad AMR exome
AF:
0.259
Gnomad ASJ exome
AF:
0.213
Gnomad EAS exome
AF:
0.684
Gnomad FIN exome
AF:
0.205
Gnomad NFE exome
AF:
0.0985
Gnomad OTH exome
AF:
0.184
GnomAD4 exome
AF:
0.142
AC:
206696
AN:
1459874
Hom.:
25852
Cov.:
33
AF XY:
0.149
AC XY:
107979
AN XY:
726318
show subpopulations
African (AFR)
AF:
0.197
AC:
6583
AN:
33442
American (AMR)
AF:
0.257
AC:
11460
AN:
44590
Ashkenazi Jewish (ASJ)
AF:
0.216
AC:
5630
AN:
26108
East Asian (EAS)
AF:
0.688
AC:
27295
AN:
39676
South Asian (SAS)
AF:
0.389
AC:
33521
AN:
86242
European-Finnish (FIN)
AF:
0.194
AC:
10089
AN:
52076
Middle Eastern (MID)
AF:
0.165
AC:
952
AN:
5762
European-Non Finnish (NFE)
AF:
0.0908
AC:
100924
AN:
1111622
Other (OTH)
AF:
0.170
AC:
10242
AN:
60356
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
10584
21169
31753
42338
52922
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4222
8444
12666
16888
21110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.174
AC:
26493
AN:
151904
Hom.:
3429
Cov.:
32
AF XY:
0.188
AC XY:
13954
AN XY:
74244
show subpopulations
African (AFR)
AF:
0.193
AC:
8020
AN:
41472
American (AMR)
AF:
0.214
AC:
3266
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
0.207
AC:
716
AN:
3466
East Asian (EAS)
AF:
0.671
AC:
3435
AN:
5122
South Asian (SAS)
AF:
0.398
AC:
1917
AN:
4812
European-Finnish (FIN)
AF:
0.204
AC:
2153
AN:
10566
Middle Eastern (MID)
AF:
0.143
AC:
42
AN:
294
European-Non Finnish (NFE)
AF:
0.0950
AC:
6456
AN:
67928
Other (OTH)
AF:
0.180
AC:
377
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1007
2014
3021
4028
5035
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
290
580
870
1160
1450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.136
Hom.:
8522
Bravo
AF:
0.178
TwinsUK
AF:
0.0914
AC:
339
ALSPAC
AF:
0.0867
AC:
334
ESP6500AA
AF:
0.195
AC:
858
ESP6500EA
AF:
0.105
AC:
902
ExAC
AF:
0.219
AC:
26546
Asia WGS
AF:
0.439
AC:
1524
AN:
3478
EpiCase
AF:
0.0978
EpiControl
AF:
0.0986

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Type 2 diabetes mellitus Uncertain:1
Jan 01, 2016
Centre for Mendelian Genomics, University Medical Centre Ljubljana
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was classified as: Uncertain significance. The following ACMG criteria were applied in classifying this variant: BP6,PP5. This variant was detected in homozygous state. -

PPP1R3A-related disorder Benign:1
Oct 17, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 7581368) -

Insulin resistance, susceptibility to Other:1
Aug 01, 1995
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.19
T
Eigen
Uncertain
0.50
Eigen_PC
Uncertain
0.49
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.72
T
MetaRNN
Benign
0.0000088
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.8
L
PhyloP100
3.2
PrimateAI
Benign
0.28
T
PROVEAN
Uncertain
-2.4
N
REVEL
Benign
0.081
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.014
D
Polyphen
0.98
D
Vest4
0.15
MPC
0.31
ClinPred
0.044
T
GERP RS
5.6
Varity_R
0.20
gMVP
0.37
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1799999; hg19: chr7-113518434; COSMIC: COSV52878180; COSMIC: COSV52878180; API